Evidence reviews
Source-linked interpretation that keeps study design, maturity and limitations visible.
Interpretation of the World's First Official Compliance Standard for Longevity Medicine Clinics An Authoritative Guide to the Department of Health – Abu Dhabi (DoH) Healthy Longevity Medicine Clinic Standard with Asia-Pacific Practice Recommendations
The TASCAP Academic Committee interprets the world's first official standard for longevity medicine clinics, issued by Abu Dhabi's Department of Health in October 2024 and effective April 2025, covering MDT qualifications, the three-tier classification of diagnostics and interventions, and copyright attribution.
Read full article →Interpretation of China's Group Standard Clinical Testing Guidelines for Anti-Aging Medicine An Evidence-Based Tiered Framework Based on T/FDSA and Biological Age Assessment
An interpretation of the Clinical Testing Guidelines for Anti-Aging Medicine, drafted by Beijing Geriatric Hospital and governed by T/FDSA, covering the AgeDev age-deviation formula, a three-tier (strong / conditional / emerging) testing map, and quality control specifications.
Read full article →Interpretation of China's Group Standard Basic Requirements for the Setup of Anti-Aging Medicine Clinics A Clinic Development and MDT Operations Guide Based on T/FDSA 0100-2025
An interpretation of the T/FDSA 0100-2025 group standard, covering clinic positioning, facilities, the six-role MDT configuration table, and the closed-loop service workflow of assessment → intervention → monitoring → referral.
Read full article →